Charter Research & Investment Group’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$1.91M Hold
50,005
2.24% 19
2016
Q2
$2.09M Sell
50,005
-700
-1% -$28.7K 2.39% 16
2016
Q1
$2.04M Sell
50,705
-1,435
-3% -$57.7K 2.33% 16
2015
Q4
$2.22M Sell
52,140
-700
-1% -$32.2K 2.58% 14
2015
Q3
$2.51M Sell
52,840
-50
-0.1% -$2.55K 3.31% 10
2015
Q2
$2.62M Sell
52,890
-350
-0.7% -$17.7K 2.91% 11
2015
Q1
$2.63M Sell
53,240
-155
-0.3% -$7.41K 2.91% 11
2014
Q4
$2.44M Buy
+53,395
New +$2.59M 2.67% 13

Other funds holding SNY

Charter Research & Investment Group's SNY Position: Q3 2016 in Review

Charter Research & Investment Group held its Sanofi (SNY) position steady in Q3 2016 at 50,005 shares worth $1.91M. The position accounts for 2.24% of the portfolio, ranked #19.

Charter Research & Investment Group first reported a position in SNY in Q4 2014 and has held it in 8 quarters since. The position peaked at $2.63M in Q1 2015. 448 funds tracked by Wall St. Rank hold SNY as of Q3 2016.

  • Charter Research & Investment Group held 50,005 shares of Sanofi worth $1.91M as of Q3 2016.
  • Charter Research & Investment Group left its Sanofi share count unchanged in Q3 2016.
  • Sanofi made up 2.24% of Charter Research & Investment Group's portfolio in Q3 2016, its #19 holding.
  • Charter Research & Investment Group first reported a position in Sanofi in Q4 2014 and has held it in 8 quarters since.
  • Charter Research & Investment Group's Sanofi position peaked at $2.63M in Q1 2015.
  • 448 funds tracked by Wall St. Rank held Sanofi as of Q3 2016.

Based on Charter Research & Investment Group's 13F filing for Q3 2016, filed 14 Nov 2016.